n(g),n(g')-dimethyl-l-arginine has been researched along with Erectile Dysfunction in 11 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Erectile Dysfunction: The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the relation between ADMA, symmetric dimethylarginine (SDMA) and L-arginine concentrations and erectile dysfunction." | 7.78 | Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction. ( Barassi, A; Ciociola, F; Colpi, GM; Corsi, MM; Dozio, E; Fermo, I; Finati, E; Ghilardi, F; Melzi d'Eril, GV; Paroni, R, 2012) |
| "Sildenafil is the most used treatment of erectile dysfunction, however a large part of patients do not respond to therapy." | 5.46 | Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: Impact on erectile dysfunction therapy. ( Azevedo, AMM; Brites-Anselmi, G; Coeli-Lacchini, FB; de Almeida Belo, V; de Andrade, MF; Hirsch, E; Lacchini, R; Molina, CAF; Pinheiro, LC; Tanus-Santos, JE; Tucci, S, 2017) |
| "Erectile dysfunction is related to penile arterial endothelial nitric oxide production." | 5.33 | Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction. ( Jackson, G; Lambert-Hammill, M; Lumb, PJ; Lyttle, K; Solomon, H; Wierzbicki, AS, 2006) |
| "ED is associated with established coronary atherosclerosis, but its relationship with early coronary atherosclerosis and CED is unknown." | 5.33 | Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. ( Elesber, AA; Lennon, RJ; Lerman, A; Lerman, LO; Mathew, V; McConnell, JP; Nelson, RE; Prasad, A; Pumper, G; Solomon, H, 2006) |
| " We investigated the relation between ADMA, symmetric dimethylarginine (SDMA) and L-arginine concentrations and erectile dysfunction." | 3.78 | Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction. ( Barassi, A; Ciociola, F; Colpi, GM; Corsi, MM; Dozio, E; Fermo, I; Finati, E; Ghilardi, F; Melzi d'Eril, GV; Paroni, R, 2012) |
| "Sildenafil is the most used treatment of erectile dysfunction, however a large part of patients do not respond to therapy." | 1.46 | Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: Impact on erectile dysfunction therapy. ( Azevedo, AMM; Brites-Anselmi, G; Coeli-Lacchini, FB; de Almeida Belo, V; de Andrade, MF; Hirsch, E; Lacchini, R; Molina, CAF; Pinheiro, LC; Tanus-Santos, JE; Tucci, S, 2017) |
| "Erectile dysfunction is related to penile arterial endothelial nitric oxide production." | 1.33 | Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction. ( Jackson, G; Lambert-Hammill, M; Lumb, PJ; Lyttle, K; Solomon, H; Wierzbicki, AS, 2006) |
| "ED is associated with established coronary atherosclerosis, but its relationship with early coronary atherosclerosis and CED is unknown." | 1.33 | Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. ( Elesber, AA; Lennon, RJ; Lerman, A; Lerman, LO; Mathew, V; McConnell, JP; Nelson, RE; Prasad, A; Pumper, G; Solomon, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azevedo, AMM | 1 |
| Brites-Anselmi, G | 1 |
| Pinheiro, LC | 1 |
| de Almeida Belo, V | 1 |
| Coeli-Lacchini, FB | 1 |
| Molina, CAF | 1 |
| de Andrade, MF | 1 |
| Tucci, S | 1 |
| Hirsch, E | 1 |
| Tanus-Santos, JE | 1 |
| Lacchini, R | 1 |
| Kataoka, T | 1 |
| Hotta, Y | 1 |
| Maeda, Y | 1 |
| Kimura, K | 1 |
| Hu, LL | 1 |
| Zhang, KQ | 1 |
| Tian, T | 1 |
| Zhang, H | 1 |
| Fu, Q | 1 |
| Cui, K | 1 |
| Luan, Y | 1 |
| Tang, Z | 1 |
| Rao, K | 1 |
| Wang, T | 1 |
| Chen, Z | 1 |
| Wang, S | 1 |
| Liu, J | 1 |
| Wang, D | 1 |
| Durmus, N | 1 |
| Toylu, A | 1 |
| Evcim, S | 1 |
| Soner, BC | 1 |
| Demir, O | 1 |
| Kahraman, E | 1 |
| Demir, T | 1 |
| Irer, B | 1 |
| Gidener, S | 1 |
| Atabey, N | 1 |
| Esen, A | 1 |
| Zhavbert, ES | 1 |
| Tarasov, SA | 1 |
| Dugina, JL | 1 |
| Sergeeva, SA | 1 |
| Gamidov, SI | 2 |
| Mazo, EB | 2 |
| Epstein, OI | 1 |
| Gasanov, RV | 1 |
| Sotnikova, EM | 1 |
| Aktoz, T | 1 |
| Aktoz, M | 1 |
| Tatlı, E | 1 |
| Kaplan, M | 1 |
| Turan, FN | 1 |
| Barutcu, A | 1 |
| Atakan, IH | 1 |
| Demir, M | 1 |
| Altun, A | 1 |
| Paroni, R | 1 |
| Barassi, A | 1 |
| Ciociola, F | 1 |
| Dozio, E | 1 |
| Finati, E | 1 |
| Fermo, I | 1 |
| Ghilardi, F | 1 |
| Colpi, GM | 1 |
| Corsi, MM | 1 |
| Melzi d'Eril, GV | 1 |
| Wierzbicki, AS | 1 |
| Solomon, H | 2 |
| Lumb, PJ | 1 |
| Lyttle, K | 1 |
| Lambert-Hammill, M | 1 |
| Jackson, G | 1 |
| Elesber, AA | 1 |
| Lennon, RJ | 1 |
| Mathew, V | 1 |
| Prasad, A | 1 |
| Pumper, G | 1 |
| Nelson, RE | 1 |
| McConnell, JP | 1 |
| Lerman, LO | 1 |
| Lerman, A | 1 |
2 trials available for n(g),n(g')-dimethyl-l-arginine and Erectile Dysfunction
| Article | Year |
|---|---|
Study of the correlation between clinical efficiency of impaza and serum ADMA level.
Topics: Adult; Antibodies; Arginine; Double-Blind Method; Erectile Dysfunction; Humans; Male; Nitric Oxide S | 2008 |
Prophylactics of erectile dysfunction in patients with metabolic syndrome.
Topics: Adult; Aged; Antibodies; Antihypertensive Agents; Arginine; Erectile Dysfunction; Humans; Hypoglycem | 2009 |
9 other studies available for n(g),n(g')-dimethyl-l-arginine and Erectile Dysfunction
| Article | Year |
|---|---|
Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: Impact on erectile dysfunction therapy.
Topics: Amidohydrolases; Arginine; Biomarkers; Erectile Dysfunction; Humans; Male; Nitrites; Phosphodiestera | 2017 |
Testosterone Deficiency Causes Endothelial Dysfunction via Elevation of Asymmetric Dimethylarginine and Oxidative Stress in Castrated Rats.
Topics: Animals; Arginine; Castration; Endothelium; Erectile Dysfunction; Humans; Male; Nitric Oxide; Oxidat | 2017 |
Probucol improves erectile function via Activation of Nrf2 and coordinates the HO-1 / DDAH / PPAR-γ/ eNOS pathways in streptozotocin-induced diabetic rats.
Topics: Amidohydrolases; Animals; Arginine; Blood Glucose; Body Weight; Cyclic GMP; Diabetes Mellitus, Exper | 2018 |
Involvement of DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP Pathways in Human Tissue Kallikrein 1 Protecting Erectile Function in Aged Rats.
Topics: Aging; Amidohydrolases; Animals; Arginine; Cyclic AMP; Cyclic GMP; Cyclooxygenase 2; Cytochrome P-45 | 2017 |
Time-course changes of nLDL-induced erectile dysfunction.
Topics: Animals; Arginine; Disease Models, Animal; Endothelium, Vascular; Erectile Dysfunction; Hyperlipidem | 2017 |
Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease.
Topics: Arginine; Coronary Artery Disease; Erectile Dysfunction; Humans; Male; Middle Aged; Severity of Illn | 2010 |
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction.
Topics: Adult; Arginine; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Middle Aged | 2012 |
Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Arginine; Blood Pressure; C-Reactive Protein; Cardiovascular Di | 2006 |
Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis.
Topics: Arginine; C-Reactive Protein; Coronary Artery Disease; Endothelium, Vascular; Erectile Dysfunction; | 2006 |